Filomena Di Rienzo
Overview
Explore the profile of Filomena Di Rienzo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Intiso D, Centra A, Gravina M, Copetti M, Fontana A, Bartolo M, et al.
Neurotrauma Rep
. 2024 Jul;
5(1):606-616.
PMID: 39036429
Low vitamin D (VD) has been associated with poor clinical course in several neurological diseases. Supplementation has been suggested to improve outcomes. Severe acquired brain injury (sABI) subjects have low...
2.
Intiso D, Centra A, Gravina M, Chiaramonte A, Bartolo M, Di Rienzo F
Toxins (Basel)
. 2023 Aug;
15(8).
PMID: 37624266
Stroke patients can develop spasticity and spasticity-related pain (SRP). These disorders are frequent and can contribute to functional limitations and disabling conditions. Many reports have suggested that higher doses than...
3.
Intiso D, Centra A, Amoruso L, Gravina M, Di Rienzo F
Front Neurol
. 2022 Jul;
13:906402.
PMID: 35800084
Background: The COVID-19 disease can affect subjects suffering from myasthenia gravis (MG) and worsen its clinical course, leading to intensive care unit (ICU) admission. Critically ill subjects can develop a...
4.
Intiso D, Centra A, Bartolo M, Gatta M, Gravina M, Di Rienzo F
BMC Neurol
. 2022 Feb;
22(1):50.
PMID: 35148710
Background: Intensive care unit acquired weakness (ICUAW), embraces an array of disorders labeled "critical illness polyneuropathy" (CIP), "critical illness myopathy" (CIM) or "critical illness polyneuromyopathy" (CIPNM). Several studies have addressed...
5.
Intiso D, Centra A, Giordano A, Santamato A, Amoruso L, Di Rienzo F
J Rehabil Med
. 2021 Dec;
54:jrm00257.
PMID: 34935988
Patients with COVID-19 may develop a range of neurological disorders. We report here 4 COVID-19 subjects with intensive care unit-acquired weakness and their functional outcome. In addition, a scoping review...
6.
Intiso D, Simone V, Bartolo M, Santamato A, Ranieri M, Gatta M, et al.
Toxins (Basel)
. 2020 May;
12(5).
PMID: 32397674
Spasticity is a common disabling disorder in adult subjects suffering from stroke, brain injury, multiple sclerosis (MS) and spinal cord injury (SCI). Spasticity may be a disabling symptom in people...
7.
Intiso D, Fontana A, Copetti M, Amoruso L, Bartolo M, Santamato A, et al.
J Musculoskelet Neuronal Interact
. 2020 Mar;
20(1):18-26.
PMID: 32131367
Background: Critical illness polyneuropathy and myopathy (CIPNM) is a disabling neuropathy that occurs in intensive care unit (ICU) subjects. It was hypothesized that a low serum level or deficiency of...
8.
Intiso D, Bartolo M, Santamato A, Di Rienzo F
PM R
. 2018 Jan;
10(6):636-645.
PMID: 29366918
Level Of Evidence: IV.
9.
Intiso D, Di Rienzo F, Fontana A, Tolfa M, Bartolo M, Copetti M
Eur J Phys Rehabil Med
. 2017 Apr;
53(6):910-919.
PMID: 28417610
Background: Critical illness polyneuropathy and myopathy (CIPNM) frequently occur in intensive care unit (ICU) critically ill subjects; about 55-70% of subjects achieve full recovery. CIPNM can occur in ICU subjects...
10.
Intiso D, Santamato A, Di Rienzo F
Disabil Rehabil
. 2016 Oct;
39(21):2123-2133.
PMID: 27764971
Objective: To investigate whether electrical stimulation (ES) as an adjunct to BTX-A boosts botulinum activity and whether the combined therapeutic procedure is more effective than BTX-A alone in reducing spasticity...